| Closed |
SWOG-8367 |
Combined Modality Treatment of Regional Non-Small Lung Cancer |
12/1/1983 |
10/1/1986 |
|
|
Published
|
| Closed |
SWOG-8944 |
A Study of Carboplatin (CBDCA) in Refractory Multiple Myeloma |
3/1/1990 |
6/1/1991 |
48% |
|
Published
|
| Closed |
SWOG-8378 |
Evaluation of Fludarabine Phosphate in Chronic Lympho- cytic Leukemia |
12/5/1983 |
6/15/1987 |
|
|
|
| Closed |
SWOG-9436 (NABTC-9403) (NCI T94-0184) |
A Phase I/II Trial of Paclitaxel (Taxol®) Chemotherapy for Recurrent Malignant Glioma |
4/18/1995 |
2/4/1998 |
95% |
|
Published
|
| Closed |
SWOG-8518 |
Study of Combined Modality Treatment For Inoperable Squamous Cell Carcinoma of the Esophagus (Stage III By Moss Classification) |
10/15/1986 |
6/1/1988 |
|
|
|
| Closed |
SWOG-717 |
Combination Drug (Cytoxan (NSC-26271), Vincristine (NSC-67574), Methotrexate (NSC-740) and 5-Fluorouracil (NSC-19893) Chemotherapy of Solid Tumor in Adults |
7/29/1968 |
|
4% |
|
|
| Closed |
SWOG-8377 |
High Dose Cyclophosphamide, VP-16-213 and Cis-Platinum Followed by Autologous Bone Marrow Transplantation in the Treatment of Relapsing or Germ Cell Tumors |
6/11/1984 |
9/27/1985 |
|
|
|
| Closed |
SWOG-8735 |
A Phase II Study of Recombinant Human Interferon- Alpha and Recombinant Human Interferon-Gamma in Previously Untreated Patients with Chronic Myelogenous Leukemia |
4/1/1988 |
5/15/1990 |
57% |
|
|
| Closed |
S0114 |
EGFRvIII Peptide Vaccine |
11/1/2002 |
6/1/2006 |
47% |
|
|
| Closed |
S0533 |
Cisplatin/Etoposide/RT/Docetaxel and Three Cohorts of Bevacizumab-Advanced Stage III NSCLC |
6/15/2006 |
3/1/2010 |
16% |
|
Published
|
| Closed |
S0727 |
Pancreas Ph I/II gemcitabine, erlotinib, IMC-A12 |
3/1/2008 |
9/1/2010 |
100% |
|
Published
|
| Closed |
S0717 |
Advanced Renal |
6/15/2008 |
4/1/2009 |
4% |
|
|
| Closed |
S0905 |
Ph I / Randomized Ph II Mesothelioma Cediranib |
3/15/2010 |
2/15/2016 |
91% |
|
Published
|
| Closed |
S0806 |
Phase I/II DLBCL Vorinostat with R-CHOP |
11/15/2010 |
10/1/2013 |
100% |
|
Published
|
| Closed |
S1211 |
PII Optimal Induction for HRMM |
10/12/2012 |
|
100% |
|
|
| Closed |
S1221 |
BRAF Mutant Metastatic Cancer |
7/1/2013 |
|
39% |
|
|
| Closed |
S1313 |
Ph Ib/II Rando mFOLFIRINOX+PEGPH20 vs mFOLFIRINOX Alone in Good PS Met Pancreatic Adenocarcinoma |
1/6/2014 |
|
73% |
|
|
| Closed |
S1318 |
PII Blinatumomab/POMP for Elderly Ph-Neg ALL |
1/12/2015 |
9/29/2021 |
98% |
|
|
| Open |
S1905 |
PI/II OBI-3424 for R/R T-ALL/T-LBL |
8/17/2020 |
|
22% |
|
|
| Closed |
SWOG-8014 |
Colchicine in Refractory Chronic Lymphocytic Leukemia |
7/7/1980 |
10/23/1981 |
|
|
|
